2025-11-06T12:37:20-06:00 2024-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2024-01-01 522252820 ASSOCIATION FOR ACCESSIBLE MEDICINES ASSO 2022497100 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 JOHN A MURPHY III PRESIDENT AND CEO 2022497100 2025-11-05 1 1 MARK C THOMAS P00362982 3019860600 2025-11-06 2024 2025-03-06 01:10:19Z JOHN MURPHY III 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 21539161 0 X WWW.ACCESSIBLEMEDS.ORG X 2000 DC PROMOTE THE INTEREST OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY. 24 24 24 200 0 0 0 0 21263207 20025808 578548 1107258 393635 406095 22235390 21539161 319150 184500 0 0 6900923 7223679 0 0 0 10728780 10884387 17948853 18292566 4286537 3246595 23610075 22475133 12114192 7732655 11495883 14742478 THE ORGANIZATION FOSTERS AND PROMOTES THE INTERESTS OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY. 0 0 GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY WITH RESPECT TO FEDERAL, STATE, AND MUNICIPAL RULES, LAWS, AND ORDERS AFFECTING THE INDUSTRY. POLICY & STRATEGIC ALLIANCES - IDENTIFY POLICY ISSUES AFFECTING THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRIES AND FACILITATE DEVELOPMENT OF POLICY POSITIONS AMONG OUR MEMBER COMPANIES; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT, AND STATE AND INTERNATIONAL BODIES TO EDUCATE AND COMMUNICATE POLICY POSITIONS ON STRATEGIC PRIORITIES; DEVELOP DATA TO SUPPORT ADVOCACY INITIATIVES AND PUBLISH WHITE PAPERS, REPORTS AND OTHER POLICY RESOURCES; BUILD RELATIONSHIPS WITH THIRD-PARTY STAKEHOLDERS ACROSS SUPPLY CHAIN, PATIENT, PROVIDER, CONSUMER, AND OTHER SECTORS TO SUPPORT ADVOCACY INITIATIVES. COMMUNICATIONS & MARKETING - EDUCATING POLICYMAKERS, MEDIA, PATIENTS AND OTHER STAKEHOLDERS ABOUT THE ECONOMIC AND THERAPEUTIC CONTRIBUTIONS OF GENERIC AND BIOSIMILARS MEDICINES AS WELL AS THEIR SAFETY AND EFFICACY; PRODUCING AND SHARING PATIENT AND TAXPAYER SAVINGS DATA AND STORIES OF PATIENTS WHOSE HEALTH IS SAVED, IMPROVED AND MAINTAINED BY GENERIC AND BIOSIMILARS MEDICINES; DISSEMINATING INSTRUCTIONAL MATERIALS AND CURRICULUM TO PROMOTE THE SAFE USE, STORAGE AND DISPOSAL OF PRESCRIPTION MEDICINES. 0 0 0 1 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 60 0 1 24 1 0 0 0 0 0 0 0 0 X 24 24 0 0 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ASSOCIATION 2022497100 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 KEREN HARUVI BOARD CHAIR 2.00 X X 0 0 0 BOB HOFFMAN BOARD VICE CHAIR 2.00 X X 0 0 0 JEFF BURD BOARD TREASURER 2.00 X X 0 0 0 ROB ALBERT BOARD MEMBER 2.00 X 0 0 0 CHRISTINE BAEDER BOARD MEMBER 2.00 X 0 0 0 DAN DISCHNER BOARD MEMBER 2.00 X 0 0 0 MATT ERICK BOARD MEMBER 2.00 X 0 0 0 MARC FALKIN BOARD MEMBER 2.00 X 0 0 0 KEVIN FORTIER BOARD MEMBER 2.00 X 0 0 0 GRETCHEN FRITZ BOARD MEMBER 2.00 X 0 0 0 HAFRUN FRIDRIKSDOTTIR BOARD MEMBER 2.00 X 0 0 0 ABHAY GANDHI BOARD MEMBER 2.00 X 0 0 0 SANJAY GUPTA BOARD MEMBER 2.00 X 0 0 0 MILAN KALAWADIA BOARD MEMBER 2.00 X 0 0 0 MARC KIKUCHI BOARD MEMBER 2.00 X 0 0 0 EMILY KING BOARD MEMBER 2.00 X 0 0 0 BRIAN MCCORMICK BOARD MEMBER 2.00 X 0 0 0 PAUL MCMAHON BOARD MEMBER 2.00 X 0 0 0 PUNIT PATEL BOARD MEMBER 2.00 X 0 0 0 BRANDON ROCKWELL BOARD MEMBER 2.00 X 0 0 0 VEERAPPAN SUBRAMANIAN BOARD MEMBER 2.00 X 0 0 0 MARYLL TOUFANIAN BOARD MEMBER 2.00 X 0 0 0 ARUN VERMA BOARD MEMBER 2.00 X 0 0 0 VICTORIA WOHLFIEL CHERRY BOARD MEMBER 2.00 X 0 0 0 CHRYS KOKINO BOARD MEMBER 2.00 X 0 0 0 JOHN DUCKER BOARD MEMBER 2.00 X 0 0 0 PAT MCINTOSH BOARD MEMBER 2.00 X 0 0 0 DAVID GAUGH INTERIM PRESIDENT & CEO / EXEC VP 40.00 X 722230 0 52704 KARIN HESSLER GENERAL COUNSEL AND SECRETARY 40.00 X 457889 0 38274 JOHN MURPHY III PRESIDENT AND CEO 40.00 X 111403 0 6076 CRAIG BURTON SVP, POLICY & STRATEGIC ALLIANCES 40.00 X 455119 0 55723 GIUSEPPE RANDAZZO SVP, SCIENCES & REGULATORY AFFAIRS 40.00 X 446188 0 28963 KATHERINE RAAB VP, FGA 40.00 X 400495 0 46452 BRIAN HART VP, COMMUNICATIONS 40.00 X 330616 0 37591 RACHELLE KOSKY CONTROLLER 40.00 X 278894 0 31449 3202834 0 297232 22 0 1 0 AVALERE HEALTH 1201 NEW YORK AVE NW STE 1000 WASHINGTON DC 20005 CONSULTING & DATA ANALYTICS 648000 GOODWIN PROCTER LLP 100 NORTHERN AVE BOSTON MA 02210 LEGAL SERVICES 584465 MARRIOTT BUSINESS SERVICES INC PO BOX 403003 ATLANTA GA 303846474 MEETING SERVICES 570935 IQVIA INC 100 IMS DRIVE PARSIPPANY NJ 07054 RESEARCH STUDIES AND DATABASE SUBSCRIPTI 554467 CORE STAGING INC 5 ANDREW WAY ARDEN NC 28704 MEETING A/V, STAGING & PRODUCTION SERVIC 327098 23 MEMBERSHIP DUES 900099 18264605 18264605 MEETING REVENUE 900099 1451203 1451203 BIOSIMILAR COUNCIL DUES 900099 310000 310000 20025808 1107258 1107258 390635 0 390635 390635 390635 MISCELLANEOUS 900099 15460 15460 15460 21539161 20041268 0 1497893 X 184500 1388576 4953651 147571 385180 348701 1155003 131912 2158053 2263589 353236 214481 305773 1259722 172079 1220611 236494 80407 DUES & SUBSCRIPTIONS 635385 RESEARCH PROJECT 581078 MAINTENANCE & TAXES 116564 18292566 17046731 17153993 462864 631157 2692502 2080378 841811 612124 579013 579071 4679656 3498788 23610075 22475133 754378 1032000 4830945 1756021 6528869 4944634 12114192 7732655 X 11495883 14742478 11495883 14742478 23610075 22475133 3246595 0 X X 0 1 X 1 0 0 0 0 18574605 4867309 -16651448 -11784139 6129620 -17913759 1752500 1161903 590597 826726 805199 21527 113276 113276 0 612124 DEPOSITS 25037 OPERATING RIGHT-OF-USE ASSETS 3473751 3498788 OPERATING LEASE LIABILITIES 4944634 4944634 X 21539161 0 21539161 0 21539161 18292566 0 18292566 0 18292566 PART X, LINE 2: THE ASSOCIATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ASSOCIATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. THE ASSOCIATION'S TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES GENERALLY FOR THREE YEARS AFTER FILING. 0 AMERICAN CONSUMER INSTITUTE CCR 13337 GLEN TAYLOR LN OAK HILL VA 20171 208601897 501(C)(3) 15000 0 GENERAL CONTRIBUTION CONSUMER ACTION 57 POST ST STE 611 SAN FRANCISCO CA 94104 237172908 501(C)(3) 12500 0 GENERAL CONTRIBUTION NATIONAL CONSUMERS LEAGUE 1701 K ST NW STE 1200 WASHINGTON DC 20006 530242038 501(C)(3) 25000 0 GENERAL CONTRIBUTION NATIONAL TAXPAYERS UNION 122 C ST NW STE 650 WASHINGTON DC 20001 521009116 501(C)(4) 25000 0 GENERAL CONTRIBUTION PREVENT CANCER FOUNDATION 333 JOHN CARLYLE ST STE 635 ALEXANDRIA VA 22314 521429544 501(C)(3) 12000 0 GENERAL CONTRIBUTION R STREET INSTITUTE 1212 NEW YORK AVE NW STE 900 WASHINGTON DC 20005 263477125 501(C)(3) 35000 0 GENERAL CONTRIBUTION THIRD WAY 1025 CONNECTICUT AVE NW STE 400 WASHINGTON DC 20036 201734070 501(C)(4) 60000 0 GENERAL CONTRIBUTION 5 2 X X X 1 1 X X X X X X 0 0 0 DAVID GAUGH INTERIM PRESIDENT & CEO / EXEC VP 481685 0 240545 0 0 0 27600 0 25104 0 774934 0 0 0 CRAIG BURTON SVP, POLICY & STRATEGIC ALLIANCES 336023 0 119096 0 0 0 23000 0 32723 0 510842 0 0 0 KARIN HESSLER GENERAL COUNSEL AND SECRETARY 338793 0 119096 0 0 0 22984 0 15290 0 496163 0 0 0 GIUSEPPE RANDAZZO SVP, SCIENCES & REGULATORY AFFAIRS 330828 0 115360 0 0 0 24415 0 4548 0 475151 0 0 0 KATHERINE RAAB VP, FGA 307457 0 93038 0 0 0 23000 0 23452 0 446947 0 0 0 BRIAN HART VP, COMMUNICATIONS 253366 0 77250 0 0 0 0 0 37591 0 368207 0 0 0 RACHELLE KOSKY CONTROLLER 214236 0 64658 0 0 0 16550 0 14899 0 310343 0 0 0 FORM 990, PART VI, SECTION A, LINE 4 IN 2024, AAM AMENDED ITS BYLAWS TO CLARIFY THAT DIRECTORS WHO HAVE RECEIVED A WAIVER FOR CERTAIN QUALIFICATIONS ARE ELIGIBLE TO BE ELECTED AS TREASURER OF THE BOARD. HOWEVER, SUCH DIRECTORS ARE INELIGIBLE TO SERVE AS CHAIR OR VICE CHAIR OF THE BOARD. FORM 990, PART VI, SECTION A, LINE 6 AAM HAS ONE CLASS OF REGULAR VOTING MEMBERS THAT MUST MEET THE FOLLOWING CRITERIA. A REGULAR MEMBER SHALL BE A CORPORATION, PARTNERSHIP OR OTHER LEGAL ENTITY THAT DERIVES MORE THAN TWENTY-FIVE PERCENT (25%) OF ITS NET REVENUES IN THE UNITED STATES FROM THE DEVELOPMENT, COMMERCIALIZATION, MANUFACTURE, SALE AND/OR MARKETINGS OF FINISHED DOSE PRODUCTS THAT ARE (1) PRODUCTS DESCRIBED IN ABBREVIATED NEW DRUG APPLICATIONS FILED WITH THE U.S. FOOD & DRUG ADMINISTRATION; (2) PRODUCTS SOLD AS AUTHORIZED GENERIC DRUGS IN THE U.S., (3) BIOSIMILAR PRODUCTS, AS DESCRIBED IN SECTION 351(K) OF THE PUBLIC HEALTH SERVICE ACT, AS AMENDED; AND/OR (4) DRUG EFFICACY STUDY IMPLEMENTATION (DESI) PRODUCTS. REGULAR MEMBERS HAVE FULL VOTING RIGHTS ON A "ONE COMPANY, ONE VOTE" BASIS. EACH REGULAR MEMBER SHALL DESIGNATE IN WRITING ONE PERSON TO EXERCISE THE RIGHTS OF THE REGULAR MEMBER IN THIS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A AAM'S VOTING MEMBERS ELECT THE DIRECTORS OF AAM'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO AAM'S BYLAWS, AAM'S BOARD OF DIRECTORS HAVE THE AUTHORITY TO AMEND THE BYLAWS. FURTHER, PURSUANT TO THE D.C. NOT-FOR-PROFIT CORPORATION ACT, EXTRAORDINARY ACTIONS MUST BE APPROVED BY THE VOTING MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B AAM STAFF AND LEGAL COUNSEL PROVIDED THE INITIAL REVIEW OF THE FORM 990. THE FORM 990 WAS THEN REVIEWED BY THE FINANCE AND AUDIT COMMITTEE. FINALLY, IT WAS FORWARDED TO ALL THE DIRECTORS OF THE BOARD BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C AAM REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REMINDING DIRECTORS AND OTHERS SUBJECT TO THE POLICY PERIODICALLY OF THE APPLICABILITY OF THE POLICY AND THE APPROPRIATE MANNER OF COMPLYING WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF THE PRESIDENT IS DETERMINED BASED ON THE PERFORMANCE OF THE PRESIDENT AND COMPARABLE SALARIES OF EXECUTIVES OF SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY THE PRESIDENT BASED ON COMPENSATION DATA OF SIMILARLY SITUATED EMPLOYEES AT SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ASSOCIATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS 1,728,864. LITIGATION FEES 524,240. OTHER PROFESSIONAL FEES 10,485. FORM 990, PART XII, LINE 2C: THE FINANCE AND AUDIT COMMITTEE OF THE BOARD OVERSEES THE AUDIT.